Purpose: Given the unique features of the liver, it is necessary to combine immunotherapy with other therapies to improve its efficacy in patients of advanced cancer with liver metastases (LM). High-intensity focused ultrasound (HIFU) ablation is now widely used in clinical practice and can enhanced immune benefits. The study is intended to prospectively evaluate the safety and clinical feasibility of HIFU ablation in combination with systemic immunotherapy for patients with liver metastases.

Methods: The study enrolled 14 patients with LM who received ultrasound-guided HIFU ablation combined with immune checkpoint inhibitors (ICIs) such as anti-programmed cell death protein 1 (anti-PD-1 agents manufactured in China) at Mianyang Central Hospital. Patients were followed up for adverse events (AEs) during the trial, using the CommonTerminology Criteria for Adverse Events v5.0(CTCAE v5.0) as the standard. Tumour response after treatment was assessed using computerized tomography.

Results: The 14 patients (age range, 35-84 years) underwent HIFU ablation at 19 metastatic sites and systemic immunotherapy. The mean lesion volume was 179.9 cm3 (maximum: 733.1 cm3). Median follow-up for this trial was 9 months (range: 3-21) months. The study is clinically feasible and acceptable to patients.

Conclusion: This prospective study confirmed that HIFU combined with immunotherapy is clinically feasible and safe for treating liver metastases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226133PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0306595PLOS

Publication Analysis

Top Keywords

hifu ablation
16
liver metastases
12
high-intensity focused
8
focused ultrasound
8
ablation combined
8
combined immunotherapy
8
treating liver
8
systemic immunotherapy
8
adverse events
8
clinically feasible
8

Similar Publications

Article Synopsis
  • The study assesses a novel MRI radiomics stacking ensemble learning model for predicting outcomes of high-intensity focused ultrasound (HIFU) ablation in patients with uterine fibroids.
  • Data from 360 patients is analyzed, utilizing deep learning for automated segmentation and various statistical methods for feature selection to enhance predictive accuracy.
  • Results showed that among the models tested, the Multilayer Perceptron (MLP) performed the best with an area under the curve (AUC) of 0.858, indicating strong potential for preoperative prognosis using MRI features.
View Article and Find Full Text PDF
Article Synopsis
  • Developed a nomogram to predict the effectiveness of high-intensity focused ultrasound (HIFU) for treating uterine fibroids by analyzing oxytocin levels and sonographic features of fibroids.
  • Conducted a retrospective study of 60 patients, utilizing logistic regression to identify key predictive factors like myoma type, blood flow, and oxytocin classification, resulting in a model assessed using R language.
  • The model demonstrated strong predictive ability with an area under the curve of 0.887 and good calibration, suggesting it can effectively guide clinicians in selecting appropriate patients for HIFU treatment.
View Article and Find Full Text PDF

High-intensity focused ultrasound (HIFU) is a noninvasive soft tissue ablation technique, which utilizes ultrasound energy to induce thermal coagulation necrosis in targeted tissues. Whether this high energy causes side effects in vivo, such as the formation of peptide bonds, has not been fully investigated. Glycylglycine is the simplest dipeptide and hence is often used as a model compound for peptide studies.

View Article and Find Full Text PDF

This paper describes the design and initial proof-of-concept of a single pre-clinical transcranial focused ultrasound (FUS) system capable of performing histotripsy (mechanical ablation), hyperthermia, blood-brain barrier opening (BBBO), sonodynamic therapy, or neuromodulation in a murine brain. We have termed it the All-in-One FUS system for murine brain studies, which is the first FUS system of its kind. The 1.

View Article and Find Full Text PDF

Purpose: In patients with prostate cancer (PCa), focal therapy with High-Intensity Focused Ultrasound (HIFU) combined with benign prostatic hyperplasia (BPH) surgery has been used to improve immediate post-operative voiding symptoms. Our study aimed to evaluate the functional outcomes of patients undergoing simultaneous holmium laser enucleation of the prostate (HoLEP) + HIFU and compare them to those who underwent HoLEP for bladder outlet obstruction secondary to BPH.

Methods: We performed retrospective review of patients who underwent HoLEP + HIFU or HoLEP between June 2017 and May 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!